Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
DeafMonitor aggregates Deaf-community news and credits every story to its original publisher. This story was reported by PR Newswire.
Read the full story at PR Newswire
Read the full story at PR Newswire